Product Images Tenofovir Disoproxil Fumarate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Tenofovir Disoproxil Fumarate NDC 65862-421 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 150 mg (30 Tablets Bottle) - tenofovir fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 150 mg (30 Tablets Bottle) - tenofovir fig1

Not available.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg (30 Tablets Bottle) - tenofovir fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg (30 Tablets Bottle) - tenofovir fig2

Not available. seems to have failed to recognize any readable characters.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg (30 Tablets Bottle) - tenofovir fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg (30 Tablets Bottle) - tenofovir fig3

Tenofovir Disoproxil Fumarate Tablets is a prescription drug that comes in film-coated tablet form. Each tablet contains 200mg of tenofovir disoproxil fumarate, which is equivalent to 163mg of tenofovir disoproxil. This drug is manufactured by Aurobindo Pharma USA, Inc. in India and comes in a bottle of 30 tablets. The usual dosage of this drug can be found in the prescribing information. It should be stored between 20° to 257 (63° to 77°F) with allowance excursions permitted to 15° to 30°C (59° o 86°F) [see USP Controlled Room Temperature]. Before use, ensure that the seal over the bottle opening is not broken or missing, and the container should be kept tightly closed.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (30 Tablets Bottle) - tenofovir fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (30 Tablets Bottle) - tenofovir fig4

This is a description of a medication called Tenofovir Disoproxil Fumarate Tablets. It comes in a package of 30 Unit-dose Tablets and has an NDC number of 65862-819-03. The tablets contain 200g of vl oo umart, Wi s gt o 1630t otoutGsopr. The rest of the text seems to be errors and cannot be understood properly.*

tenofovir fig5

tenofovir fig5

tenofovir fig6

tenofovir fig6

This is a description of a prescription drug called Tenofovir Disoproxil Fumarate Tablets. It comes in a pack of 30310 unit dose tablets with a strength of 234mg. It is indicated for HIV-1 infected adult patients. The NDC code is 65862-820-03. The rest of the text seems to be unclear and not readable.*

tenofovir fig7

tenofovir fig7

This is a prescription drug called Tenofovir Disoproxil Fumarate Tablets, manufactured in India and distributed by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 300mg of tenofovir disoprosilfumarate, equivalent to 245mg of tenofovir disoproxi. This drug is meant to be stored at 20° to 25°C and should only be dispensed in its original container. The recommended dosage and administration are listed in the packaging insert. If the seal over the bottle opening is broken or missing, do not use it. The code TS/DRUGS/19/1993 and NDC 65862-421-30 are printed on the packaging.*

Tenofovir Structure - tenofovir str

Tenofovir Structure - tenofovir str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.